Hong Bo Lu

Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.

Echosens SA engages in the manufacture of medical imaging equipment. It focuses on developing FibroScan. The company was founded by Laurent Sandrin and Sylvain Yon on June 20, 2001 and is headquartered in Paris, France.

LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States.

Crown Bioscience International develops drug for Oncology and Metabolic Diseases. Its products include Antibodies for in vivo & in vitro studies, Tissues for CVMD research and therapeutic R&D, Recombinant cell lines, Tumor samples for oncology research & drug development. The company founded on October 22, 2013 and is headquartered in Taipei, Taiwan.

Beijing PINS Medical Co., Ltd. is a medical company based in Beijing, China. The Chinese company's main focus is on pinch medical. The company was founded in 2008. The CEO is Hongwei Hao.

Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China.

Rgenta Therapeutics, Inc. manufactures medicines for oncology and neurological disorders. The company was founded by Simon Xi, Travis Wager, and Zhiping Weng and is headquartered in Cambridge, MA.

Geneception, Inc. provides healthcare services. The company is headquartered in Cambridge, MA.

Ablaze Pharmaceuticals is a Chinese clinical-stage pharmaceutical company founded in 2021 with a mission to bring advanced targeted radiopharmaceutical therapies to benefit cancer patients. Ablaze Pharma has secured a partnership with Rayzebio, Inc., an innovative radiopharmaceutical company based in CA, to gain exclusive development and commercial rights to a series of Rayzebio's products in the greater region. The company is based in Jing'an District, China. The company leverages its team's extensive business experience and network in cross-border product development and deal making to become the leader and partner of choice in the emerging TRT market. Alex Qiao has been the CEO of the company since 2021.

Avistone Pharmaceuticals is a Chinese clinical-stage biotechnology company that specializes in precision oncology therapeutics. The company is located in China.

Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang.

RiboX Therapeutics, Inc. engages in the development of fully engineered circular RNA therapeutics. The private company is based in Shanghai, China.

Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19.

Visirna Therapeutics, Inc. manufactures and commercializes RNAi-based investigational cardiometabolic medicines. The company is based in Shanghai, China.